BACKGROUND: Levonorgestrel-releasing intrauterine system (LNG-IUS), although inserted to reduce heavy menstruation, causes irregular early transient bleeding. The objective of the study was to document quantitative changes in endometrial vessels of short- ( or =12 months) LNG users. The area, density and maturation of endometrial vessels were quantified in 19 endometrial biopsies of women with LNG-IUS and in 10 normally ovulating patients during mid-luteal phase. METHODS: Vessel maturation was evaluated by double immunostaining using anti-von Willebrand factor (endothelial cell marker) and anti-alpha Smooth Muscle Actin (vascular smooth muscle cells) antibodies. Vessel area, number and density were quantified with a novel computer-assisted ...
Background: This article is a study comparing the two most accepted forms of treatment for abnormal ...
Background: Heavy menstrual bleeding (HMB) affects 10 to 35% of women. Studies indicate LNG-IUS whic...
Background: The levonorgestrel-releasing intra-uterine system (LNg-IUS) has been used to control men...
Background: The levonorgestrel intrauterine system (LNG-IUS) is a contraceptive device that is used ...
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective contraceptive...
The main reason for discontinuation of the levonorgestrel-releasing intrauterine system (LNG-IUS) is...
Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorges...
BACKGROUND: This study was designed to develop an animal model to test the response of endometrium t...
Background: Menorrhagia, menstrual blood loss of more than 80 ml is a common health problem affectin...
OBJECTIVE To evaluate the effect of baseline bleeding patterns on rates of amenorrhea reported at 1...
Background: To study the efficacy, performance and acceptability of levonorgestrel intrauterine devi...
Objectives: Up to 60% of women remove their levonorgestrel-releasing Intrauterine System (LNG-IUS) p...
Background: Changes in menstrual bleeding patterns are a major cause of hormonal contraceptive disco...
Background: Heavy menstrual bleeding (HMB) is defined as prolonged (>7 days) or excessive menstru...
Background: The study was conducted to evaluate the cardiovascular risk markers associated with endo...
Background: This article is a study comparing the two most accepted forms of treatment for abnormal ...
Background: Heavy menstrual bleeding (HMB) affects 10 to 35% of women. Studies indicate LNG-IUS whic...
Background: The levonorgestrel-releasing intra-uterine system (LNg-IUS) has been used to control men...
Background: The levonorgestrel intrauterine system (LNG-IUS) is a contraceptive device that is used ...
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective contraceptive...
The main reason for discontinuation of the levonorgestrel-releasing intrauterine system (LNG-IUS) is...
Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorges...
BACKGROUND: This study was designed to develop an animal model to test the response of endometrium t...
Background: Menorrhagia, menstrual blood loss of more than 80 ml is a common health problem affectin...
OBJECTIVE To evaluate the effect of baseline bleeding patterns on rates of amenorrhea reported at 1...
Background: To study the efficacy, performance and acceptability of levonorgestrel intrauterine devi...
Objectives: Up to 60% of women remove their levonorgestrel-releasing Intrauterine System (LNG-IUS) p...
Background: Changes in menstrual bleeding patterns are a major cause of hormonal contraceptive disco...
Background: Heavy menstrual bleeding (HMB) is defined as prolonged (>7 days) or excessive menstru...
Background: The study was conducted to evaluate the cardiovascular risk markers associated with endo...
Background: This article is a study comparing the two most accepted forms of treatment for abnormal ...
Background: Heavy menstrual bleeding (HMB) affects 10 to 35% of women. Studies indicate LNG-IUS whic...
Background: The levonorgestrel-releasing intra-uterine system (LNg-IUS) has been used to control men...